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Background: The aim of this study was to assess the prevalence of the novel avian influenza A virus (H7N9) in
three high risk groups. The groups were divided into those exposed through infected individuals, those exposed
through poultry and those individuals exposed through the external environment, in the early stage of the
epidemic in Guangdong Province, which is located in the southern region of China.
Methods: Serologic studies were conducted among samples collected from individuals who had close contact
with the first H7N9 infected patient reported in Guangdong Province, those who were most likely exposed to the
first group of H7N9 infected poultry, and those who might have been exposed to H7N9 in the environmental
settings, namely hemagglutinin inhibition (HI) and microneutralizaiton(MN) assays using three viruses as antigens.
Results: The alignment results of the viral sequences indicated the similarity of the HA gene sequence among
viruses from exposure to infected poultry, infected humans and contaminated environments were highly
conserved. Seven samples of individuals exposed to contaminated environments were positive in the HI assay and
one sample among them was positive in the MN assay using poultry H7N9 virus as the antigen. One sample was
positive against human H7N9 virus and 3 samples were positive against environmental H7N9 among those that
were in contact with infected patients in HI assay. None of these were positive in MN assay. All HI titers of the 240
samples from those individuals in contact with infected poultry were less than 40 aganist the antigens from three viruses.
Conclusions: The results suggest that when the H7N9 virus was in the early stages of circulation in Guangdong
Province, the antigenic sites of the HA proteins of the H7N9 strain isolated from different hosts were highly conserved.
The risk of new infection is low in individuals who have contact with the infected patients, poultry or a contaminated
environment in the early stages of the circulation of the H7N9 virus.
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In March 2013, a novel reassortant avian influenza A sub-
type H7N9 virus was first detected from patients with
severe respiratory disease in Eastern China [1]. Sequencing
analysis revealed that the novel virus was of avian origin
with six internal genes from avian influenza A (H9N2)
viruses, while the haemagglutinin (HA) and neuraminidase
(NA) genes were most likely from Eurasian lineage of avian* Correspondence: kecw2011@sina.com
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unless otherwise stated.A subtype H7N3 and H11N9 [2]. Through April 2014, a
total of 411 human infections with 147 fatalities were
reported in 14 provinces and regions including Taiwan and
Hong Kong. During this time, novel H7N9 strains continued
to emerge in poultry and in the environment in several
provinces in China.
Guangdong, a southern province of China with a sub-
tropical climate, is one of the epicenters of the circulation
of novel influenza viruses [3]. In April 2013, the H7N9
virus was first detected in poultry in Guangdong, and was
then detected in environmental samples in May of that
same year. The first human infection case of H7N9 within. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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had been detected in all possible vectors of the transmission
pathway and had established its circulation in the province.
As a novel reassortant virus, the transmission and
infection of H7N9 virus remained inconclusive [4]. Both
the epidemiologic and genetic analysis have revealed that
close contact with infected poultry or a contaminated en-
vironment may be an important risk factor for H7N9 in-
fection in humans [5,6]. The limited and non-sustainable
person-to-person transmission of this novel avian flu virus
was reported in Eastern China [7]. As we had identified
H7N9 strains from all sources of possible viral infection,
namely virus isolated from infected humans, infected
poultry and environmental samples, we were able to
investigate the ability of H7N9 to transmit from poultry to
humans, from a contaminated environment to humans,
and from person to person respectively. 561 samples were
collected from these high-risk groups at the early stage of
viral infection. Serological studies of these samples provide
useful information on the circulation of H7N9. Here we
report the results of the serological screenings conducted
on samples collected from individuals in contact with
infected patients, individuals exposed to infected poultry,
and individuals exposed to environments contaminated
with H7N9 virus, in the early rise of the epidemic in
Guangdong Province, Southern China.
Results
The detection and sequence of H7N9 virus
Samples taken from poultry cages in live poultry mar-
kets were detected to be positive for H7N9 in MayFigure 1 The alignment of HA protein of 4 viruses from different orig
A/environment/Guangdong/25/2013 (H7N9) was sequenced by GDCDC. Th
[GenBank:CY146940.1] and A/chicken/SD641/Guangdong/2013 [GenBank:CY
nucleotide sequence was 99.5-99.8% to the HA gene and there are 3 differ
among the 4 viruses.2013. This was the first time that the H7N9 virus was
detected in an external environmental sample in
Guangdong Province. The first H7N9 infected patient
in Guangdong Province was confirmed with real-time
PCR, of the H7 and N9 subtype, in July 2013. The
confirmed patient, a woman of 56 years, was respon-
sible for sales and butchering of poultry in a live
poultry market for ten years. She was reported to have
killed and sold an average of 10 chickens and 5 ducks
per day before onset of symptoms. These two H7N9
viruses (from the patient and the environmental
sample) were identified as A/Huizhou/1/2013(H7N9)
and A/environment/Guangdong/25/2013 (H7N9), re-
spectively. The whole genomes of these two viruses
were sequenced and analyzed.Alignment of HA sequence among H7N9 viruses
originated from different sources
The HA gene of the viruses originating from the pa-
tient, identified as A/Huizhou/1/2013 (H7N9) [GISAID:
EPI439507] and the environmental sample, identified as
A/environment/Guangdong/25/2013 (H7N9) [GenBank:
KF667746.1] were sequenced by GDCDC. The HA gene of
viruses isolated from poultry, identified as A/chicken/
Jiangsu/SC537/2013 (H7N9) [GenBank:CY146940.1] and
A/chicken/SD641/Guangdong/2013 [GenBank:CY146908.1]
were retrieved from GenBank [8]. The similarity of nucleo-
tide sequence is 99.5-99.8% with the HA gene and there are
3 different amino acids sites of R65K, T140A and N285D of
the HA protein among the 4 viruses (Figure 1).ins. The gene sequence of HA of A/Huizhou/1/2013(H7N9) and
e gene sequence of HA of A/chicken/Jiangsu/SC537/2013 (H7N9)
146908.1] were retrieved from GenBank. The similarity of the
ent amino acids sites of R65K, T140A and N285D of the HA protein
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A total of 125 serum samples were collected from individ-
uals in close contact with the index patient who was the
first identified patient infected by H7N9 in Guangdong
Province. These individuals ranged from family members,
neighbors, healthcare personnel, workers from the live
poultry market and slaughterhouse, to those who had
social contact with the patient. The median age of the 125
individuals was 38 years (1–74 years), with 36.8% male
(Table 1).
A total of 240 serum samples were collected from those
who had possible exposure to the first H7N9 infected
poultry in Guangdong Province, including staff from live-
poultry markets, farms, poultry yards, slaughterhouses,
transports, individuals from the Animal Health Inspection
Agency and the family members of the poultry market
staff. The median age of these 240 individuals was 41 years
(1–72 years), with 67.5% male (Table 2).
A total of 196 single serum samples were collected from
individuals who might have exposure to the environment
that was contaminated with H7N9 early in the epidemic,
ranging from live poultry market managers, lodging clerks
and cleaning staff, to poultry meat vendors and butchers.
The median age of this group was 42 years (11–64 years)
with 72.4% male (Table 3).
At the time when blood samples were taken, none of
the 561 individuals showed no influenza symptoms. All
participants were taken throat swabs which were tested
negative for nucleic acid of H7N9 virus with RT-PCR.
Serological results
The 561 samples were screened for the antibodies specific to
influenza A/Huizhou/1/2013 (H7N9), A/chicken/Jiangsu/
SC537/2013 (H7N9) and A/environment/Guangdong/25/
2013 (H7N9). With a conservative cut-off value, the anti-
body titer higher than 40 was considered as a positive result.
The serology results of 561 serum along with patient and
positive control are show in Table 4. Four serum samples,
from the patient’s husband, employees and daughter respect-
ively, were positive against A/Huizhou/1/2013 (H7N9) and
A/environment/Guangdong/25/2013 (H7N9) using the HI
assay. Seven serum samples from vendors in a live poultry
market where the H7N9 virus was first found on chicken








Median age (years [interquartile
range])
40 [27–43] 35.5 [8–74](H7 Sub-type). Only one sample of an individual exposed to
a contaminated environment was positive with the con-
firmed MN assay among the 11 positive samples using HI
(Table 4).Discussion
Antigenic drift or shift of Influenza viruses takes place
when the virus is exposed to various hosts or vectors in
nature. Antigenic drift is related to climate, location and
population [9,10]. In order to elucidate the antigenic
drift, transmission and infection in the population of the
novel H7N9 virus at the onset of the epidemic and circula-
tion in southern China, three different origins of the
H7N9 virus isolated from key sources of transmission
were selected as antigens to detect the antibody to H7N9
in sera of the high risk groups who had close contact with
the first human case of H7N9, those, who had close
contact with infected poultry, or exposure to H7N9
contaminated environmental settings.
HA is the major glycoprotein envelope of the influenza
A virus and the target of almost all neutralizing antibodies
[11]. There are five antigenic epitopes (epitope A, B, C, D
and E) in the HA1 subunit and in most subtypes of influ-
enza A [12]. Most neutralizing antibodies bind to the ex-
posed loops of the receptor binding sites of HA blocking
the binding of the virus to cell receptors [13-15]. Because
these loops are highly variable, the amino acid sequence of
related antigenic sites of the five H7N9 viruses identified in
the human, poultry and environmental samples were
analyzed. There are 3 different amino acids sites of R65K,
T140A and N285D of the HA protein among viruses
isolated from humans, poultry and the environment in the
HA protein. This indicates that viral mutation has already
occurred when changing host during the early circulation
of the virus in Guangdong Province. Although the three
mutant sites do not locate in epitopes, K65R and N285D
are both close to epitope C and site T140A is close to
eptiope A, which would be helpful to the advanced protein
structure for the binding antibody. Thus cross-reactivity of
viruses originating from the three different sources was not
found in HI. However, the similarity of nucleotide
sequences of the HA gene of the three H7N9 strains from
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Male 71 24 7 23 34 3
Female 33 16 7 12 3 7




41 (2–65) 41.5 (1–72) 42 (21–52) 41 (22–60) 36 (27–56) 43 (16–50)
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of the infection in Guangdong Province.
To study the possible transmission routes of H7N9, we
screened the serum samples collected from the high-risk
groups (individuals in close contact with the index patient
and infected poultry, or exposure to a contaminated envir-
onment) against three H7N9 viruses that originated from
poultry, human and the environment. We intended to dis-
sert the possible route of transmission by serologically
screening these samples. However, our results indicated
that the positive rates of antibodies against H7N9 viruses
of three different origins were very low within the high-
risk groups. This might suggest that the infection rate of
H7N9 virus was very low within those that were in close
contact with the infected H7N9 patient, infected poultry
or contaminated environment when H7N9 was first circu-
lating in Guangdong Province. The transmission of H7N9
from person to person, from poultry to person, and from
environment to human might be low in the early stage of
viral circulation in Guangdong Province which is located
in a subtropical climate, which is a humid environment
that will favor the survival of the virus.
There are several reports that are consistent with our
findings in this study. Hsieh SM et al. reported that the HI
activity of serum from 14 close contacts to the first con-
firmed case of H7N9 infection in Taiwan were all <1:10 and
none of the close contacts had flu-like or respiratory symp-
toms during the 28 days of follow-up. This provided evi-
dence that the potential for person-to-person transmission
of H7N9 was low [16]. Li et al. reported a serologic screen-
ing study of 1251 close contacts of 82 H7N9-confirmed pa-
tients in China. They found 19 cases of respiratory
symptoms from these close contacts but all cases tested





Median age (years [interquartile range]) 40 [22–59]family members of three patients infected by H7N9 showed
negative reactions on H7N9 viral tests, although they all
had close contact with the patients during the viral shed-
ding period [17]. All of these previous reports indicated that
the novel avian-origin H7N9 virus was not easily transmit-
ted by close contact of H7N9 infected patient.
Interestingly, the highly pathogenic avian influenza A
(H5N1) virus that circulated among poultry is also
known to not be easily transmitted by close contact with
infected patients [18,19]. Although H7N9 virus binds to
both receptors of α-2-6 sialosides and α-2-3 sialosides, it
speculated that the cell binding pattern to a cell receptor
of H7N9 is similar to of the H5N1 [20].
Serologic study on 396 poultry workers identified >6%
sero-positive for H7N9 (on the basis of HI titer of ≥80),
suggesting that infected poultry might be a principal source
of human infections in Zhejiang Province [21]. Yet our
study showed low sero-positive cases from the same group
of workers, resulting in a large difference in the sero-
positive rate of H7N9 in the Provinces of Zhejiang and
Guangdong. This might be due to the difference in the
timing of sample collection. The majority of the con-
firmed cases of H7N9 were reported in Zhejiang Province
in 2013 and samples from poultry workers were collected
after 45 cases of H7N9 were confirmed. At the time of
sample collection, H7N9 or a closely related virus may
have already been in circulation in live poultry markets in
the region for a period of time in Zhejiang Province. The
samples in this study were collected in the early phase of
viral circulation in Guangdong Province. Thus, the timing
of the viral circulation was different in the two studies,
one from the established stage and one from the early
stage, which may have lead to the difference in sero-
positive rate among the high-risk groups of individuals.osure to a contaminated environment
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Individuals in contact with infected person 1 0 3
Individuals exposed to infected poultry 0 0 0
Individuals exposure to contaminated
environment
0 7 0
HI titer of serum from infected patient 1:80 1:160 1:80
HI titer of positive control 1:80 1:40 1:160
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for H7N9 among high-risk groups in Guangdong Province
should be continued in order to monitor sero-positivity
and to support the hypothesis drawn from the experimental
results.
Conclusions
Taken together, our findings suggest that in early stage of
epidemic of the novel H7N9 virus in Guangdong
Province, the sequence of the HA protein of H7N9 strains
from different hosts were highly conserved. The infection
rate of the H7N9 virus is very low among high-risk
groups. Proactive screening of individuals from the high-
risk groups of viral infection may provide clues of the
evolution of the virus in endemic regions.
Methods
Detection, isolation and sequence of H7N9 virus
Specimens from swabs from humans, poultry and envir-
onmental samples were detected with real-time PCR (The
Avian influenza virus H7N9 Real Time RT-PCR kit manu-
factured by Shanghai ZJ Bio-tech Co, LTD). The viruses
were isolated with 9-11-day-old specific pathogen free
(SPF) embryonated chicken eggs and allantoic fluids were
collected and sequenced. Eight fragments from H7N9
positive samples were amplified using PathAmpTM Flu A
Reagents (Applied Biosystems, Foster City, CA) and se-
quenced with the Ion torrent Personal Genome Machine
(Applied Biosystems, Foster City, CA). Sequence analysis
was performed using MEGA version and the alignments
were conducted with the software MEGA5.0 with MUSCLE
Algorithm.
The virus and viral inactivation
Three avian influenza H7N9 viruses were selected to
screen the samples collected from the early stages of viral
infection. A/environment/Guangdong/25/2013 (H7N9)
was isolated from the environmental samples detected at
the earliest stage of the epidemic in Guangdong Province.
A/Huizhou/1/2013 (H7N9) was isolated from the first in-
fected patient of Guangdong Province. A/chicken/Jiangsu/
SC537/2013 (H7N9) was isolated from infected poultry
purchased from Harbin Weike Biotechnology DevelopmentLtd. All three viruses were propagated in SPF grade embry-
onated chicken eggs in a Bio-Safety Level (BSL) 3 facility
and were used as the probing antigen in HI and MN assays.
The serum containing H7N9 specific antibody used as posi-
tive control was obtained from the Chinese Centers for
Disease Control (CDC). The harvested virus was inactivated
by beta-propiolactone treatment (37°C for 2 hours). Recep-
tor destroying enzyme II (RDE II) produced from Vibrio
cholera serovar 558 Ogawa was purchased from DENKA
SEIKEN Ltd. The 96-well plates were purchased from
Greiner Bio-one Suns Ltd.
The definition of high-risk groups
The high-risk groups of individuals were defined as the
following:
Those who had close contact with the infective patients
(such as household contacts and social contacts that had
contact within one meter of the patient), and those who
had direct contact with the patient (such as clinical staffs).
Those with possible exposure to poultry infected with
H7N9, including those who sold and butchered poultry,
and those who worked in the live poultry market.
Those who may have been exposed to a contaminated
environment, such as those who were exposed due to lack
of effective personal protective equipment,. These include
workers in poultry farms, slaughterhouses, live-poultry
markets, and those who are involved in transportation of
poultry.
Serum sample collection
Once the first H7N9 infections in human, poultry and the
environment were confirmed in Guangdong Province, an
investigation team composing of the staffs from both local
CDC and provincial CDC was formed to immediately
examine any possible source of the H7N9 virus. The serum
samples of high-risk groups were collected to investigate
the possible routes of transmission. All blood specimens
were collected by venipuncture and placed on ice packs
and transported to the local CDC laboratory for further
processing. Samples from individuals who had close contact
with the first H7N9 infected patient were collected
20 days later (after initial patient symptom onset) and sam-
ples from those who were exposed to infected poultry and
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initial infection. Serum was separated, and split into three
aliquots and temporarily frozen at −20°C at the local CDC
laboratory before shipping to the provincial CDC laboratory
on dry ice within 4 days. The samples were then stored at
−70°C before further assays were performed.
For the collection and use of all above-mentioned speci-
mens, written informed consent from all participants (their
parents or legal guardian in the case of a minor) involved in
the research were obtained. This study was approved by the
ethics committee of the Guangdong Provincial Center for
Disease Control and Prevention, and was in compliance
with the Helsinki Declaration.
Serological screening on the selected samples
An HI assay using horse red cells was employed for H7N9
specific antibody screening on all collected samples in a
BSL 2 facility. Serum with an HI titer higher than 40 was
defined as seropositive [22] and then subject to an MN
assay in an enhanced BSL 3 facility.
Horse RBC solution of 1% (vol/vol) was prepared by
washing with PBS containing 0.5% BSA. The serum was
treated with RDE (destroying non-specific receptor) at 1:4
(vol/vol) at 37°C for 19 hours, and then heated inactive at
56°C for 30 minutes. 20 μl concentrated horse RBCs was
added to 200 μl RDE-treated serum for 1 hr at RT, which
could remove the non-specific HI effects. After centrifuga-
tion at 2000 rpm for 3 min, the prepared serum (25 μl of
each) was diluted in two-fold serial dilutions with 25 μl PBS
in 96-well V-bottom microtiter plates. Subsequently, 25 μl
of beta-propiolactone inactivated the H7N9 virus contain-
ing 4 HAU was added to the wells and incubated at room
temperature for 20 minutes. Then, 50 μl of 1% horse RBCs
was added and the plate was incubated further for 1 hour
at room temperature before the agglutination titers were re-
corded. The HI assay results were expressed as the recipro-
cal of the last dilution of the sample that completely
inhibited haemagglutination. All assays included samples
for the positive serum control.
The positive serum samples were subjected to MN. 10 μl
of heat-inactivated sera including positive serum, negative
serum and serum samples were added to 96 well cell cul-
ture plate (Nunc Corp) and performed 2-fold serial dilu-
tions. 100TCID50/50 μl virus was added to wells and we
incubated the virus-serum mixture for 1 hr at 37°C, 5%
CO2. Back-titration, started with the virus test dilution (100
TCID50) and an additional serial 2-fold dilutions with dilu-
ents was set-up. 100 μl MDCK cells (1.5 × 104 cells /well)
was then added to each well and the plate was incubated
overnight at 37°C, 5% CO2 (18–20 hrs). The plate was fixed
with 100 μl/well of cold fixative at RT for 10 min. The virus
was detected with anti-NP monoclonal antibody (KPL Com-
pany) and HRP-goat anti-mouse IgG (SANTA CRUZE) as
secondary antibody using ELISA. The value below X(X =(Average OD of Positive cell control wells-Average OD of
negative cell control wells)/2 + (Average OD of negative cell
control wells)) was positive for neutralization activity.
Ethical approval
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